1.
Hosp Pharm
; 53(1): 55-58, 2018 Feb.
Article
in English
| MEDLINE
| ID: mdl-29434388
ABSTRACT
Dofetilide's hepatotoxicity is not well described. In this case report, we describe acute hepatocellular jaundice related to dofetilide use in a 33-year-old male being treated for atrial fibrillation. Both viral and ischemic causes of hepatocellular damage were ruled out as unlikely in this case. This case report outlines a rare yet probable report of idiosyncratic dofetilide-induced liver injury.